Welcome to the Clot Club Blog. The first rule of CLOT CLUB is: We DO talk about CLOT CLUB. If you have any questions about any of the topics discussed herein, please contact us…
Clot Club #27
A TRIO OF BIOMARKERS: A NOVEL MULTIVARIATE MODEL TO DETECT DILI & LIVER DAMAGE
Abi Kasberg, PhD
Posted: September 27, 2021
Clot Club #26
ISTH 2021
David L. McGlasson, MS, MLS(ASCP)
Posted: September 27, 2021
Clot Club #25
THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) CLINICAL TRIALS: TARGETING THE NEEDS LEFT BY CURRENT TREATMENT OPTIONS
Abi Kasberg, PhD
Posted: August 19, 2021
Clot Club #24
IN VITRO LIVER CULTURE SYSTEMS TO INVESTIGATE DILI
Abi Kasberg, PhD
Posted: July 8, 2021
Clot Club #23
HYPERCOAGULATION DURING SICKLE CELL DISEASE
Abi Kasberg, PhD
Posted: May 19, 2021
Clot Club #22
LUPUS ANTICOAGULANTS/ANTIPHOSPHOLIPID ANTIBODIES/ANTIPHOSPHOLIPID ANTIBODY SYNDROME – PART 2
David L. McGlasson, MS, MLS(ASCP)
Posted: April 29, 2021
Clot Club #21
LUPUS ANTICOAGULANTS/ANTIPHOSPHOLIPID ANTIBODIES/ANTIPHOSPHOLIPID ANTIBODY SYNDROME – PART 1
David L. McGlasson, MS, MLS(ASCP)
Posted: March 29, 2021
Clot Club #20
DETECTING HEMOGLOBIN VARIANTS DURING SICKLE CELL DISEASE RESEARCH: WHICH METHOD IS BEST?
Abi Kasberg, PhD
Posted: March 15, 2021
Clot Club #19
INSIGHTS INTO AN IMBALANCED vWF ANTIGEN TO ADAMTS-13 ACTIVITY RATIO IN COVID-19
Abi Kasberg, PhD
Posted: February 16, 2021
Clot Club #18
THSNA 2020 Virtual Meeting
David L. McGlasson, MS, MLS(ASCP)
Posted: December 8, 2020
Clot Club #17
PROPOSED MECHANISMS OF PLATELET DYNAMICS DURING COVID-19
Abi Kasberg, PhD
Posted: October 2, 2020
Clot Club #16
ACTIVATED PROTEIN C RESISTANCE (APCR), FACTOR V LEIDEN (FVL), AND A CASE REPORT OF A FAMILY WITH THE PRESENCE OF FVL OVER 5 GENERATIONS.
David L. McGlasson, MS, MLS(ASCP)
Posted: September 25, 2020
Clot Club #15
COVID-19 FREQUENTLY ASKED QUESTIONS
Abi Kasberg, PhD
Posted: September 3, 2020
Clot Club #14
COVID-19 AND CLOTTING (Part II)
David L. McGlasson, MS MLS(ASCP)
Posted: August 3, 2020
Clot Club #13
ISTH 2020
David L. McGlasson, MS MLS(ASCP)
Posted: August 3, 2020
Clot Club #12
COVID-19 AND CLOTTING
David L. McGlasson, MS MLS(ASCP)
Posted: May 26, 2020
Clot Club #11
HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) – A SENSIBLE LABORATORY APPROACH (HOPEFULLY)
David L. McGlasson, MS MLS(ASCP)
Posted: April 2, 2020
Clot Club #10
THE LATEST RESEARCH ON DIRECT ORAL ANTICOAGULANT (DOAC) INTERFERENCES IN TESTING
David L. McGlasson, MS MLS(ASCP)
Posted: January 28, 2020
Clot Club #9
THE CHROMOGENIC FACTOR X ASSAY (CFX)
David L. McGlasson, MS MLS(ASCP)
Posted: December 10, 2019
Clot Club #8
CANNABINOID EFFECTS ON COAGULATION? DOES ORGANIC WEED MESS WITH YOUR BLOOD FLOW?
David L. McGlasson, MS MLS(ASCP)
Posted: September 26, 2019
Clot Club #7
LABORATORY TESTS FOR VON WILLEBRAND FACTOR (VWF)
David L. McGlasson, MS MLS(ASCP)
Posted: August 20, 2019
Clot Club #6
HTRS 2019 CONFERENCE SUMMARY
David L. McGlasson, MS MLS(ASCP)
Posted: June 25, 2019
Clot Club #5
FACTOR XIII
Diapharma Group, Inc.
Posted: April 30, 2019
Clot Club #4
HEPARIN IN THE NEWS – THE GENENE JONES “KILLER NURSE” STORY
David L. McGlasson, MS MLS(ASCP)
Posted: April 30, 2019
Clot Club #3
HOW TO MONITOR HEPARIN THERAPY. STILL A CONTROVERSY?
David L. McGlasson, MS MLS(ASCP)
Posted: March 22, 2019
Clot Club #2
UPDATE ON THE DIRECT ORAL ANTICOAGULANTS (DOACs): WHERE ARE WE IN THE LABORATORY ALMOST TEN YEARS LATER?
David L. McGlasson, MS MLS(ASCP)
Posted: February 7, 2019
Clot Club #1
“HERE THE CLOT THICKENS” – HEMOPHILIA A & B
David L. McGlasson, MS MLS(ASCP)
Posted: January 31, 2019
About David L. McGlasson, MS MLS(ASCP)
